Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H15NO7S2 |
Molecular Weight | 337.369 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
Stereo Comments | MM2 minimum energy of Z and E are 288.5886 and 451.3651 kcal/mol respectively |
SHOW SMILES / InChI
SMILES
CC(C)(C)[N+](\[O-])=C\C1=C(C=C(C=C1)S(O)(=O)=O)S(O)(=O)=O
InChI
InChIKey=OVTCHWSLKGENKP-GHXNOFRVSA-N
InChI=1S/C11H15NO7S2/c1-11(2,3)12(13)7-8-4-5-9(20(14,15)16)6-10(8)21(17,18)19/h4-7H,1-3H3,(H,14,15,16)(H,17,18,19)/b12-7-
AstraZeneca developed disufenton (NXY-059), a free radical trapping agent, for the treatment of ischaemic stroke and other brain injuries. Nevertheless, large clinical trial (3306 versus 1722 patients) was neutral, providing no evidence for the efficacy of disufenton sodium in patients with stroke. One study using rat cortical brain slices concluded that NXY-059 improved neuronal survival. However, another study in mouse neuroblastoma cells reported no effect. Another study reported that NXY-059 restored endothelial blood-brain. Histological analyses revealed several therapeutic advantages associated with disufenton sodium treatment following acute acoustic trauma, including reductions in inner and outer hair cell loss; reductions in acute acoustic trauma-induced loss of calretinin-positive afferent nerve fibers in the spiral lamina; and reductions in fibrocyte loss within the spiral ligament. However, AstraZeneca terminated the development program.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Free radical Sources: https://www.ncbi.nlm.nih.gov/pubmed/29673616 |
PubMed
Title | Date | PubMed |
---|---|---|
Neuroprotection for stroke: current status and future perspectives. | 2012 |
|
Neuroprotection for ischaemic stroke: translation from the bench to the bedside. | 2012 Jul |
|
Potential implication of the chemical properties and bioactivity of nitrone spin traps for therapeutics. | 2012 Jun |
|
Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity? | 2016 |
|
HPN-07, a free radical spin trapping agent, protects against functional, cellular and electrophysiological changes in the cochlea induced by acute acoustic trauma. | 2017 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID50168467
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY | |||
|
797K01YF1M
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY | |||
|
3162
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY | |||
|
6913176
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY | |||
|
m4676
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY | Merck Index | ||
|
168021-77-0
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY | |||
|
C83681
Created by
admin on Fri Dec 15 15:42:03 GMT 2023 , Edited by admin on Fri Dec 15 15:42:03 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)